The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Bisphosphonate nephrotoxicity
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The small GTP-binding protein rac regulates growth factor-induced membrane ruffling
Ridley, A. J., Paterson, H. F., Johnston, C. L., Diekmann, D., & Hall, A. (1992) · Cell · doi:10.1016/0092-8674(92)90164-8 · Cited by 3,652
Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis
Black, D. M., Delmas, P. D., Eastell, R., Reid, I. R., Boonen, S., Cauley, J. A., Cosman, F., Lakatos, P., Leung, P. C., Man, Z., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067312 · Cited by 2,986
Zoledronic Acid and Clinical Fractures and Mortality after Hip Fracture
Lyles, K. W., Colón-Emeric, C. S., Magaziner, J. S., Adachi, J. D., Pieper, C. F., Mautalen, C., Hyldstrup, L., Recknor, C., Nordsletten, L., Moore, K. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa074941 · Cited by 2,003
Chesnut, C. H., Skag, A., Christiansen, C., Recker, R., Stakkestad, J. A., Hoiseth, A., Felsenberg, D., Huss, H., Gilbride, J., Schimmer, R. C., et al. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040325 · Cited by 1,229
Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma
Berenson, J. R., Lichtenstein, A., Porter, L., Dimopoulos, M. A., Bordoni, R., George, S., Lipton, A., Keller, A., Ballester, O., Kovacs, M. J., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602223340802 · Cited by 1,081
Cellular and molecular mechanisms of action of bisphosphonates
Rogers, M. J., Gordon, S., Benford, H. L., Coxon, F. P., Luckman, S. P., Monkkonen, J., & Frith, J. C. (2000) · Cancer · doi:10.1002/1097-0142(20000615)88:12+<2961::aid-cncr12>3.0.co;2-l · Cited by 977
Bisphosphonates: A review of their pharmacokinetic properties
Lin, J. H. (1996) · Bone · doi:10.1016/8756-3282(95)00445-9 · Cited by 932
Intravenous Zoledronic Acid in Postmenopausal Women with Low Bone Mineral Density
Reid, I. R., Brown, J. P., Burckhardt, P., Horowitz, Z., Richardson, P., Trechsel, U., Widmer, A., Devogelaer, J.-P., Kaufman, J.-M., Jaeger, P., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011807 · Cited by 877
Bisphosphonates: from the laboratory to the clinic and back again
Russell, R. G. G., & Rogers, M. J. (1999) · Bone · doi:10.1016/s8756-3282(99)00116-7 · Cited by 840
Rosen, L. S., Gordon, D., Tchekmedyian, S., Yanagihara, R., Hirsh, V., Krzakowski, M., Pawlicki, M., de Souza, P., Zheng, M., Urbanowitz, G., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.105 · Cited by 729
Lipton, A., Theriault, R. L., Hortobagyi, G. N., Simeone, J., Knight, R. D., Mellars, K., Reitsma, D. J., Heffernan, M., & Seaman, J. J. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000301)88:5<1082::aid-cncr20>3.0.co;2-z · Cited by 665
Integrin-mediated Signals Regulated by Members of the Rho Family of GTPases
Clark, E. A., King, W. G., Brugge, J. S., Symons, M., & Hynes, R. O. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.142.2.573 · Cited by 603
BARISONI, L., KRIZ, W., MUNDEL, P., & D'AGATI, V. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v10151 · Cited by 557
Collapsing Focal Segmental Glomerulosclerosis Following Treatment with High-Dose Pamidronate
MARKOWITZ, G. S., APPEL, G. B., FINE, P. L., FENVES, A. Z., LOON, N. R., JAGANNATH, S., KUHN, J. A., DRATCH, A. D., & D'AGATI, V. D. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1261164 · Cited by 466
Self-citationBody, J.-J., Diel, I. J., Lichinitser, M. R., Kreuser, E. D., Dornoff, W., Gorbunova, V. A., Budde, M., & Bergström, B. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg367 · Cited by 413
Kyle, R. A., Yee, G. C., Somerfield, M. R., Flynn, P. J., Halabi, S., Jagannath, S., Orlowski, R. Z., Roodman, D. G., Twilde, P., & Anderson, K. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.1269 · Cited by 409
Toxic acute tubular necrosis following treatment with zoledronate (Zometa)
Markowitz, G. S., Fine, P. L., Stack, J. I., Kunis, C. L., Radhakrishnan, J., Palecki, W., Park, J., Nasr, S. H., Hoh, S., Siegel, D. S., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00071.x · Cited by 384
Self-citationRenal Failure with the Use of Zoledronic Acid
(2003) · New England Journal of Medicine · doi:10.1056/nejm200310233491721 · Cited by 367
Amin, D., Cornell, S., Gustafson, S., Needle, S., Ullrich, J., Bilder, G., & Perrone, M. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41388-4 · Cited by 281
Delmas, P. D., Adami, S., Strugala, C., Stakkestad, J. A., Reginster, J., Felsenberg, D., Christiansen, C., Civitelli, R., Drezner, M. K., Recker, R. R., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21918 · Cited by 258
Safety of intravenous and oral bisphosphonates and compliance with dosing regimens
Conte, P., & Guarneri, V. (2004) · The Oncologist · doi:10.1634/theoncologist.9-90004-28 · Cited by 241
Ringe, J. D., Dorst, A., Faber, H., Ibach, K., & Sorenson, F. (2003) · Osteoporosis International · doi:10.1007/s00198-003-1425-0 · Cited by 172
Zhang, D., Udagawa, N., Nakamura, I., Murakami, H., Saito, S., Yamasaki, K., Shibasaki, Y., Morii, N., Narumiya, S., Takahashi, N., et al. (1995) · Journal of Cell Science · doi:10.1242/jcs.108.6.2285 · Cited by 169
Cellular focal segmental glomerulosclerosis: Clinical and pathologic features
Stokes, M. B., Valeri, A. M., Markowitz, G. S., & D'Agati, V. D. (2006) · Kidney International · doi:10.1038/sj.ki.5001903 · Cited by 158
Self-citationIbandronate: A Clinical Pharmacological and Pharmacokinetic Update
Barrett, J., Worth, E., Bauss, F., & Epstein, S. (2004) · The Journal of Clinical Pharmacology · doi:10.1177/0091270004267594 · Cited by 150
Ibandronate in osteoporosis: preclinical data and rationale for intermittent dosing
Bauss, F., & Russell, R. G. G. (2004) · Osteoporosis International · doi:10.1007/s00198-004-1612-7 · Cited by 148
Thiébaud, D., Burckhardt, P., Melchior, J., Eckert, P., Jacquet, A. F., Schnyder, P., & Gobelet, C. (1994) · Osteoporosis International · doi:10.1007/bf01623227 · Cited by 112
Ibandronate in the treatment of prostate cancer associated painful osseous metastases
Heidenreich, A., Elert, A., & Hofmann, R. W. (2002) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500574 · Cited by 104
Podocyte injury associated glomerulopathies induced by pamidronate
Barri, Y. M., Munshi, N. C., Sukumalchantra, S., Abul‐Ezz, S. R., Bonsib, S. M., Wallach, J., & Walker, P. D. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00426.x · Cited by 104
Rogers, M. J., Ji, X., Russell, R. G. G., Blackburn, G. M., Williamson, M. P., Bayless, A. V., Ebetino, F. H., & Watts, D. J. (1994) · Biochemical Journal · doi:10.1042/bj3030303 · Cited by 102
Pfister, T., Atzpodien, E., & Bauss, F. (2003) · Toxicology · doi:10.1016/s0300-483x(03)00257-9 · Cited by 92
Renal Tolerability Profile of Novel, Potent Bisphosphonates in Two Short‐Term Rat Models
Green, J. R., Seltenmeyer, Y., Jaeggi, K. A., & Widler, L. (1997) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1997.tb01964.x · Cited by 87
Zoledronic Acid and Renal Toxicity: Data from French Adverse Effect Reporting Database
Munier, A., Gras, V., Andréjak, M., et al. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1e589 · Cited by 79
広井, 恵., Kameda, T., Hiura, K., Mano, H., Miyazawa, K., Nakamaru, Y., Watanabe-Mano, M., Okuda, N., Shimada, J., Yamamoto, Y., et al. (1999) · Calcified Tissue International · doi:10.1007/s002239900606 · Cited by 74
Lühe, A., Künkele, K., Haiker, M., Schad, K., Zihlmann, C., Bauss, F., Suter‐Dick, L., & Pfister, T. (2008) · Toxicology in Vitro · doi:10.1016/j.tiv.2008.01.006 · Cited by 68
FROMM, G. A., Vega, E., Plantalech, L., Galich, A. M., & Mautalén, C. (1991) · Osteoporosis International · doi:10.1007/bf01625440 · Cited by 62
Oh, W. K., Proctor, K., Nakabayashi, M., Evan, C. P., Tormey, L. K., Daskivich, T. J., Antràs, L., Smith, M. R., Neary, M. P., & Duh, M. S. (2007) · Cancer · doi:10.1002/cncr.22504 · Cited by 46
Cal, J. C., & Daley‐Yates, P. T. (1990) · Toxicology · doi:10.1016/0300-483x(90)90088-x · Cited by 44
Acute Renal Effects of Intravenous Bisphosphonates in the Rat
Pfister, T., Atzpodien, E., Bohrmann, B., & Bauss, F. (2005) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2005.pto_160.x · Cited by 43
Sauter, M., Jülg, B. D., Porubský, Š., Cohen, C., Fischereder, M., Sitter, T., Schlöndorff, D., & Gröne, H. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.02.189 · Cited by 42
Pamidronate-associated nephrotoxicity in a patient with Langerhans's histiocytosis
Lockridge, L., Papac, R. J., & Perazella, M. A. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.33933 · Cited by 41
Self-citationPamidronate-induced nephrotoxic tubular necrosis – a case report
Smetana, S. S., Michlin, A., Rosenman, E., Biro, A., Boaz, M., & Katzir, Z. (2004) · Clinical Nephrology · doi:10.5414/cnp61063 · Cited by 41
Cited by
KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease
Stevens, P. E., Ahmed, S. B., Carrero, J. J., Foster, B., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., et al. (2024) · Kidney International · doi:10.1016/j.kint.2023.10.018 · Cited by 8,530
Stopeck, A. T., Lipton, A., Body, J.-J., Steger, G. G., Tonkin, K., de Boer, R. H., Lichinitser, M., Fujiwara, Y., Yardley, D. A., Viniegra, M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.7101 · Cited by 1,597
Denosumab and bisphosphonates: Different mechanisms of action and effects
Baron, R., Ferrari, S., & Russell, R. G. G. (2011) · Bone · doi:10.1016/j.bone.2010.11.020 · Cited by 715
A single-dose study of denosumab in patients with various degrees of renal impairment
Block, G. A., Bone, H. G., Fang, L., Lee, E., & Padhi, D. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1613 · Cited by 340
Bisphosphonate-associated adverse events
Papapetrou, P. D. (2009) · Hormones · doi:10.14310/horm.2002.1226 · Cited by 312
Metadata
- Authors
- Perazella, M. A., & Markowitz, G. S.
- Venue
- Kidney International
- Publisher
- Elsevier BV
- Published
- 2008-12
- Volume
- 74
- Issue
- 11
- Pages
- 1385-1393
- ISSN
- 0085-2538 (ISSN-L)
- OpenAlex
- W4256619470
- Cited by
- 363
- References
- 42
- FWCI
- 6.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.